Handbook of Pharmaceutical Manufacturing Formulations, Third Edition (3rd Ed.) Volume Six, Sterile Products
Auteur : Niazi Sarfaraz K.
The Handbook of Pharmaceutical Manufacturing Formulations, Third Edition: Volume Six, Sterile Products is an authoritative and practical guide to the art and science of formulating drugs for commercial manufacturing. With thoroughly revised and expanded content, this sixth volume of a six-volume set, compiles data from FDA and EMA new drug applications, patents and patent applications, and other sources of generic and proprietary formulations including author?s own experience, to cover the broad spectrum of cGMP formulations and issues in using these formulations in a commercial setting. A must-have collection for pharmaceutical manufacturers, educational institutions, and regulatory authorities, this is an excellent platform for drug companies to benchmark their products and for generic companies to formulate drugs coming off patent.
Features:
Largest source of authoritative and practical formulations, cGMP compliance guidance and self-audit suggestions
Differs from other publications on formulation science in that it focuses on readily scalable commercial formulations that can be adopted for cGMP manufacturing
Tackles common difficulties in formulating drugs and presents details on stability testing, bioequivalence testing, and full compliance with drug product safety elements
Written by a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines
Part I Regulatory and Manufacturing
Chapter 1. Sterile Manufacturing Formulations Template
Chapter 2. Inspection of Sterile Product Manufacturing Facilities
Chapter 3. New Drug Application for Sterilized Products
Chapter 4. Validation of Cleaning Process
Chapter 5. Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
Chapter 6. Analysis of the Expression Construct in Cells Used for Production of rDNA-Derived Protein Products
Chapter 7. Stability Testing of Biotechnological/Biological Products
Chapter 8. Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products
Chapter 9. Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process
Chapter 10. Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products
Chapter 11. Essential Clean-Room Design Elements
PartII Manufacturing Formulations
Sterile Product Formulations
Part III Commercial Pharmaceutical Formulations
Commercial Pharmaceutical Formulations
Index
Sarfaraz K. Niazi, Ph.D., a well-recognized authority on drug and dosage form development including biological drugs and alternative medicines. He is Founder and Executive Chairman of Adello Biologics, LLC, (formerly, Therapeutic Proteins International, LLC), a biosimilar products company located in Chicago, IL, Piscataway, NJ and Cashel, Ireland. As an entrepreneur, Niazi has raised hundreds of millions of dollars and became recognized as an inductee into the Chicago Entrepreneur Hall of Fame.Niazi began his career teaching pharmaceutical sciences at the University of Illinois, College of Pharmacy where he was tenured before entering the industry at Abbott International. He departed Abbott as an Abbott Volwiler Fellow to pursue his passion, first through global consulting and later through the founding a biosimilar products company.
A prolific inventor with scores of patents, most prominently in the field of bioprocessing technology, Niazi is currently the largest single holder of bioprocess technology patents. His other inventions span a broad category of technologies, new chemical entities, new formulations, new analytical methodologies, and much more. He has hands on experience in developing chemical, botanical and biological products, from discovery to regulatory approval. With over 50 ISBNs under his name, Niazi has authored many landmark books in the field of pharmaceutical sciences.
He currently serves as Adjunct Professor at the University of Illinois College of Pharmacy, Ad Hoc faculty at the University of Houston, Texas, the HEJ Research Institute, Karachi, and the National University of Science and Technology, Islamabad. He has also served as a Foreign Professor at the HEJ Research Institute, Karachi. He serves on the editorial board of the journal MOJ Proteomics & Bioinformatics (MOJPB) and starting 2017, as Chief Editor of International Journal of Biosimilars. He also serves as Member of National
Date de parution : 12-2019
21.6x27.9 cm
Thème de Handbook of Pharmaceutical Manufacturing Formulations... :
Mots-clés :
biotechnology products; cGMP compliance; clean-room design elements; Pre-approval inspections; cleaning process; Stability and bioequivalence testing; drug application; Packaging commodity development; EU guidelines; Formulating drugs; GMP audit template; Changes to aNDAs; and aBLAs; pharmaceutical manufacturing formulations; cGMP formulations; rDNA-derived protein products; regulatory agencies; bioequivalence testing; stability testing; biological drugs; sterile manufacturing formulations; drug applications; sterile products; viral safety evaluation; Insulin Lispro Protamine Suspension; Edetate Disodium; Injection USP; Drug Product Containers; MCB; ISO Class; Drug Product; Media Fill Run; Aseptic Processing; Drug Substance; Unprocessed Bulk; Cell Bank; Laminar Flow Clean Rooms; Bulk Pharmaceutical Chemicals; MCB; Sterility Test Methods; Iv Infusion; Viral Clearance Studies; Postchange Product; HEPA Filter; Viral Clearance; Ich Q6B; Cell Substrate; Clean Room; Post-change Product
